Scientists link specific gene variants to post-vaccine myocarditis and pericarditis

New genetic clues reveal why some people may be predisposed to myocarditis or pericarditis after COVID-19 vaccination, offering...

Is a vegan diet the right choice for your child?

A major review reveals that vegan diets can be safe and healthy for children if meticulously planned and...

New smartphone app can help detect heart attacks and strokes

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes...

Targeting cGAS shows promise for treating cardiac dysfunction after cardiac arrest

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiac dysfunction is a prevalent and serious...

New therapy targets emotional processing to manage chronic pain

A new study led by UNSW Sydney and Neuroscience Research Australia (NeuRA) shows that targeting emotional processing is...

Exercise and diet advice misses the mark in improving heart health around the globe

A leading cardiovascular disease researcher from Simon Fraser University is ringing the alarm on universal recommendations intended to...

Microscopic structural changes in the aging heart may reduce risk of arrhythmias

Virginia Tech researchers at the Fralin Biomedical Research Institute at VTC have discovered that microscopic structural changes in...

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

A major 72-week trial shows tirzepatide leads to double-digit weight loss and greater waist reduction than semaglutide, reshaping...

Higher McCance Brain Care Score linked to lower stroke risk in women

Women with a higher McCance Brain Care Score (BCS) – a score that measures physical, lifestyle, and social-emotional...

Study shows cardiovascular benefits of GLP-1RAs in patients following bariatric surgery

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major...

Measles cases surge in the United States amid falling vaccination rates

The United States is in the midst of the second-highest year of measles cases since 2000, when the...

Living in disadvantaged neighborhoods linked to earlier menopause

A new study led by the Harvard Pilgrim Health Care Institute highlights the significant impact of living in...

New guideline aims to help primary care clinicians diagnose and treat hypertension

A new guideline to diagnose and treat hypertension is aimed at helping primary care clinicians, including family physicians,...

Tirzepatide outperforms semaglutide in weight loss clinical trial

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy)...

HIV uses circular RNAs to evade immunity and boost replication

In a groundbreaking discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have identified a...

MRI technique reveals the heart’s functional age

Scientists at the University of East Anglia (UEA) have developed a revolutionary new way of uncovering the 'true...

Trump won’t force Medicaid to cover GLP-1S for obesity. A few states are doing it anyway.

When Page Campbell's doctor recommended she try an injectable prescription drug called Wegovy to lose weight before scheduling...

Controlling key health risk factors can eliminate early death risk from high blood pressure

A new study led by researchers at Tulane University suggests that people with high blood pressure can significantly...

Early TAVR shows greatest stroke reduction in patients aged 65 to 70

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old...

Residual inflammation can linger in psoriasis patients despite skin treatment

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics,...

Cardiac ‘digital twins’ provide clues to more personalized heart treatments

For the first time, researchers from King's College London, Imperial College London and The Alan Turing Institute, have created over 3,800 anatomically accurate digital hearts to investigate how age, sex and lifestyle factors influence heart disease and electrical function.

Creating cardiac 'digital twins' at this scale has helped scientists discover that age and obesity cause changes in the heart's electrical properties, which could explain why these factors are linked to a higher risk of heart disease.

The results, published today in Nature Cardiovascular Research, show the opportunities that cardiac digital twins at scale offer to better understand the impact of lifestyle on the health and function of the heart across different populations.

With the help of the cardiac digital twins, they also found that differences in electrocardiogram (ECG) readings between men and women are primarily due to differences in heart size, not how the heart conducts electrical signals.

These insights could help clinicians refine treatments, such as tailoring heart device settings for men and women or identifying new drug targets for specific groups.

They hope that this deeper understanding of the heart in different groups could lead to more personalised care and treatment for those with heart conditions.

The cardiac digital twins were created using real patient's data and ECG readings from the UK Biobank and a cohort of patients with heart disease. These then work as a digital replica of the patient's heart which can be used to explore functions of the heart that are hard to measure directly.

Recent advances in machine learning and AI helped the researchers to create this volume of digital twins, reducing some of the manual tasks and allowing them to be built quicker.

More broadly, a digital twin is a computer model that simulates an object or process in the physical world. They can be costly and time intensive to make but can offer new insights into how the physical system is or could behave.

When applied to healthcare, a digital twin could predict how a patient's disease will develop and how patients are likely to respond to different treatments.

Professor Steven Niederer, senior author and Chair in Biomedical Engineering at Imperial College London who undertook the research whilst at King's College London, said: "Our research shows that the potential of cardiac digital twins goes beyond diagnostics.

"By replicating the hearts of people across the population, we have shown that digital twins can offer us deeper insights into the people at risk of heart disease. It also shows how lifestyle and gender can affect heart function."

These insights will help refine treatments and identify new drug targets. By developing this technology at scale, this research paves the way for their use in large population studies. This could lead to personalized treatments and better prevention strategies, ultimately transforming how we understand and treat heart diseases."

Professor Pablo Lamata, report author and professor of biomedical engineering at King's College London

Dr. Shuang Qian, lead author and visiting research associate at The Centre for Medical Engineering, King's College London, said: "The digital heart models we've built lay the foundation for the next step in our research – linking heart function to our genes. This could help us understand how genetic variations influence heart function in a way that's never been done before. This could lead to more precise and personalised care for patients in the future."

Source:

King's College London

Journal reference:

Qian, S., et al. (2025). Developing cardiac digital twin populations powered by machine learning provides electrophysiological insights in conduction and repolarization. Nature Cardiovascular Research. doi.org/10.1038/s44161-025-00650-0.


Source: http://www.news-medical.net/news/20250516/Cardiac-digital-twins-provide-clues-to-more-personalized-heart-treatments.aspx

Inline Feedbacks
View all comments
guest